Nitric Oxide Therapy for Heart Failure in African Americans: Putting Guidelines Into Action

1
Nitric Oxide Therapy for Heart Failure in African
AmericansPutting Guidelines Into Action
2
(No Transcript)
3
Effect of ISDN/HYD on All-cause Mortality in
V-HeFT I
4
V-HeFT II Annual Mortality Rate
5
Clinical Trials in Heart FailureRelative Risk
Reduction in Mortality
6
Outcomes by Gender in A-HeFT
7
Average Time to Hospital Readmission for
All-cause Hospitalizations Comparing Placebo and
FDC I/H
8
(No Transcript)
9
OPTIMIZE-HF Use of Hydralazine-Nitrates at
Hospital Discharge in Black Patients With HF
10
Barriers to Improved Utilization of FDC I/H
11
(No Transcript)
12
(No Transcript)
13
Differences in Bioequivalence of Formulations of
Isosorbide Dinitrate and Hydralazine Used in
Clinical Trials
14
Overcoming the Barriers
15
Abbreviations
16
References
17
References (cont)
18
References (cont)